Rosetta Genomics Posts Q3 Revenues of $136K, Seeks $2.5M in Private Placement

The firm's net loss for the quarter was virtually flat year over year, amid a restructuring announced last month. Rosetta also said it expects to receive a notification from Nasdaq that it is not in compliance with a rule governing stockholders' equity.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories